参考文献/References:
［1］ 陈歆雅，张圣海，吴继红.表观遗传对视网膜神经节细胞发育及凋亡的调控［J］.眼科新进展，2013，33(10):994-997.
［2］ 管怀进，康丽华.白内障表观遗传学研究的现状及进展［J］.眼科新进展，2014，34(7):601-606.
［3］ 陈秋萍，崔县伟，尤梁惠，等.新生儿疾病筛查血片微量DNA提取方法的建立及其在甲基化检测中的应用［J］.中华实用儿科临床杂志，2015，30(8):615-618.
［4］ CHEN W G，CHANG Q，LIN Y，et al.Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2［J］.Science，2003，302(5646):885-889.
［5］ FENG J,ZHOU Y,CAMPBELL S L,et al.Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons［J］.Nat Neurosci，2010，13（4）:423-430.
［6］ KIMURA A，MATSUBARA K，HORIKOSHI M.A decade of histone acetylation:marking eukaryotic chromosomes with specific codes［J］.J Biochem，2005，138(6):647-662.
［7］ CAREY N，LA THANGUE N B.Histone deacetylase inhibitors:gathering pace［J］.Curr Opin Pharmacol，2006，6(4):369-375.
［8］ WANG Z，YANG D，ZHANG X，et al.Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons［J］.PLoS One，2011，6（4）:e19229.
［9］ MARKS P A.Histone deacetylase inhibitors:a chemical genetics approach to understanding cellular functions［J］.Biochim Biophys Acta，2010，1799(10/11/12):717-725.
［10］ KUNDAKOVIC M，CHEN Y，GUIDOTTI A，et al.The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes［J］.Mol Pharmacol，2009，75(2):342-354.
［11］ FATICA A，BOZZONI I.Long non-coding RNAs:new players in cell differentiation and development［J］.Nat Rev Genet，2014，15(1):7-21.
［12］ KATSAROU K,RAO A L,TSAGRIS M，et al.Infectious long non-coding RNAs［J］.Biochimie，2015，117：37-47.
［13］ 马燕凌，孙建海，魏武杰，等.结肠癌组织中肺腺癌转移相关转录本1的表达及其临床意义［J］.新乡医学院学报，2015，32(4):329-331.
［14］ QURESHI I A，MATTICK J S，MEHLER M F.Long non-coding RNAs in nervous system function and disease［J］.Brain Res，2010，1338:20-35.
［15］ HUNG T，CHANG H Y.Long noncoding RNA in genome regulation:prospects and mechanisms［J］.RNA Biol，2010，7(5):582-585.
［16］ IWATA A，NAGATA K，HATSUTA H，et al.Altered CpG methylation in sporadic Alzheimer′s disease is associated with APP and MAPT dysregulation［J］.Hum Mol Genet，2014，23(3):648-656.
［17］ MATSUMOTO L，TAKUMA H，TAMAOKA A，et al.CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson′s disease［J］.PLoS One，2010，5(11):e15522.
［18］ TAI D J，LIU Y C，HSU W L，et al.MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome［J］.Nat Commun，2016，7:10552.
［19］ GRAFF J，REI D，GUAN J S，et al.An epigenetic blockade of cognitive functions in the neurodegenerating brain［J］.Nature，2012，483(7388):222-226.
［20］ YANG W，CHAUHAN A，MEHTA S，et al.Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer′s disease［J］.Life Sci，2014，99(1/2):31-36.
［21］ QUINTI L，CHOPRA V，ROTILI D，et al.Evaluation of histone deacetylases as drug targets in Huntington′s disease models.Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model［J］.PLoS Curr，2010，2:RRN1172.
［22］ JIA H，PALLOS J，JACQUES V，et al.Histone deacetylase(HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington′s disease［J］.Neurobiol Dis，2012，46(2):351-361.
［23］ RYU H，SMITH K，CAMELO S I,et al.Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice［J］.J Neurochem，2005，93(5)：1087-1098.
［24］ GOTTESFELD J M，RUSCHE J R，PANDOLFO M.Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich′s ataxia［J］.Neurochem，2013，126(suppl 1):147-154.
［25］ KAZANTSEV A G，THOMPSON L M.Therapeutic application of histone deacetylase inhibitors for central nervous system disorders［J］.Nat Rev Drug Discov，2008，7（10）:854-868.
［26］ CHEN Y T，ZANG X F，PAN J，et al.Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection［J］.Clin Exp Pharmacol Physiol，2012，39(9):751-758.
［27］ OMRAN A，ELIMAMl D，SHALABY S，et al.MicroRNAs:a light into the "black box" of neuropediatric diseases［J］.Neuromol Med，2012，14(4):244-261.
［28］ LEE D Y，MOON J，LEE S T，et al.Distinct expression of long non-coding RNAs in an Alzheimer′s disease model［J］.J Alzheimers Dis，2015，45（3）:837-849.
［29］ MASSONE S，VASSALLO I，FIORINO G，et al.17A,a novel non-coding RNA,regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease［J］.Neurobiol Dis，2011，41(2):308-317.
［30］ ROBERTS T C，MORRIS K V，WOOD M J.The role of long non-coding RNAs in neurodevelopment,brain function and neurological disease［J］.Philos Trans R Soc Lond B Biol Sci，2014，369(1652):20130507.
［31］ HIROSE T，VIRNICCHI G，TANIGAWA A，et al.NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies［J］.Mol Biol Cell，2014，25(1):169-183.
［32］ SZAFTANSHI K，ABORAHAM K J，MEKHAIL K.Non-coding RNA in neural function,disease,and aging［J］.Front Genet，2015，6:87.
［33］ ZHANG Y，ZOU Y，WANG W，et al.Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells［J］.J Cell Biochem，2015，116（4）:542-550.
［34］ KHALIL A M，FAGHIHI M A，MODARRESI F，et al.A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome［J］.PLoS One，2008，3（1）:e1486.
相似文献/References:
[1]高丽云,李 娜,连贺强,等.表观遗传学在先天性唇腭裂发生中的作用机制研究进展[J].新乡医学院学报,2020,37(1):008.[doi:10.7683/xxyxyxb.2020.01.003]
[2]李虹艾,李帮涛,崔 兰,等.系统性红斑狼疮表观遗传学机制研究进展[J].新乡医学院学报,2018,35(12):1125.[doi:10.7683/xxyxyxb.2018.12.021]
N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(9):1125.[doi:10.7683/xxyxyxb.2018.12.021]